Neurocentria, Inc
Pharmaceuticals - Walnut Creek, California, United States
Neurocentria, Inc Employees
Neurocentria, Inc Details
Neurocentria is a clinical stage pharmaceutical company striving to develop treatments for neurodegenerative diseases such as Mild Cognitive Impairment and Alzheimer's Disease. Currently, we have positive Phase II data demonstrating strong efficacy and safety for treating Alzheimer's Disease with our primary candidate compound, and we are set to launch Phase III clinical trials.Our original candidate drug targets synapse loss and dysfunction, hallmarks of neurodegenerative disease. This compound was developed with our unique platform that allows us to visualize the function and plasticity of living synapse. Our approach offers a breakthrough opportunity to identify novel targets for augmenting synapse density/plasticity and function.Neurocentria's novel approach reverses synaptic loss, and is based on more than a decade of research at Stanford, Tsinghua University, and MIT. Neurocentria was founded by a former MIT professor, Guosong Liu M.D. Ph.D., and a renowned chemist and inventor of molecular diagnostics, Fei Mao Ph.D.
Neurocentria, Inc Technologies
Email Providers
Outlook
Load Balancers
Varnish
CMS
Wix
Hosting
Google Cloud Hosting
Other
Mobile Friendly